Skip to main content

Ascent Investment Holdings Sold 10.45% stake in Amber Enterprises; promoter offloads 5% in Max Healthcare

 WF Asian Reconnaissance Fund and Smallcap World Fund bought 77 lakh and 2,37,77,803 shares, respectively, in Max Healthcare at Rs 110.70 per share

Ascent Investment Holdings sold 10.45 percent equity stake in Amber Enterprises, the market leader in room air conditioners via open market transactions on September 11.

It sold 9,86,646 equity shares in Amber at Rs 1,837.78 per share and 23,02,173 shares at Rs 1,835.14 per share, bulk deals data available on the National Stock Exchange (NSE) showed.

As a result, its shareholding in Amber has fallen to 10.47 percent now from 20.92 percent held on June 30.

Promoter Kartar Singh sold 275,000 equity shares in Amber (representing 0.87 percent of its total paid-up equity) at Rs 1,841.33 per share on the NSE. He held 2.25 percent stake in company as of June 30.

Vittoria Fund - OC and Oxbow Master Fund acquired 1,62,171 and 4,18,075 equity shares, respectively, in Amber at Rs 1,835.03 per share. Newport Asia Partners Fund and Newport Asia Institutional Fund bought 1,73,979 and 2,21,857 shares, respectively, at Rs 1,839.48 per share.



Among others deals, Yogeshkumar C Patel sold 2,28,964 shares in Jiya Eco-Products at Rs 8.89 per share and Gretex Share Broking sold 2 lakh shares in Suumaya Lifestyle at Rs 31 per share on the NSE.

On the BSE, promoter entities sold total 5.14 percent equity stake in Max Healthcare Institute via open market transactions on September 11.

Promoter Analjit Singh sold 58,18,021 shares in company (i.e. his entire shareholding representing 0.64 percent of its total paid-up equity) at Rs 110.70 per share. Max Ventures Investment Holdings too sold 4,07,50,158 shares at the same rate. It held 10,26,31,287 equity shares (or 11.35 percent of its total paid-up equity) as of June 30.

WF Asian Reconnaissance Fund and Smallcap World Fund bought 77 lakh and 2,37,77,803 shares, respectively, in Max Healthcare at Rs 110.70 per share.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more

Similar to 2020, D-Street is at record high ahead of Budget 2021; will history repeat itself?

  Experts are of the view that a repeat of 2020 or what happened in March might not be possible but some consolidation cannot be ruled out. Back in March when everyone wanted to write-off 2020 from their books, hope and liquidity supported markets and investor sentiment. Nobody thought that after touching a 3-year low in March 2020, benchmark indices would give double-digit returns by the end of the year. The S&P BSE Sensex and Nifty50 rallied by about 15 percent in 2020 and the big outperformance came from the small and midcap stocks. The rally is still continuing in 2021. The S&P BSE Sensex, which climbed Mount 49K, is up over 3 percent while the Nifty50 is up over 4 percent so far in January. Sensex scaling the 49,000-mark and Nifty50 touching 14,500 levels ahead of the Budget 2021 could make anyone cautious about the strength of the rally. Back in January 2020, both Sensex and Nifty touched fresh highs ahead of Budget, and then the market fell like a pack of cards. The ...
Post a Comment
Read more